The 71st in Charlie’s series on growing innovative entrepreneurism in the STL region with Lu Alleruzzo of Immunophotonics, a biotech company that has developed a novel drug which is intended to make you allergic to your own cancer.
For information, log on to

Charlie talks with Jim Merkel, author of “Making of An Icon: The Dreamers, Schemers, and the Hard Hats Who Built the Gateway Arch”, about the anniversary of the capping of the Gateway Arch.